Weekly Epoetin Alfa During Adjuvant Chemotherapy for Breast Cancer: Effect on Hemoglobin Levels and Quality of Life
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Clinical Breast Cancer
- Vol. 6 (2), 132-142
- https://doi.org/10.3816/cbc.2005.n.015
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Feasibility of Quantifying the Effects of Epoetin Alfa Therapy on Cognitive Function in Women with Breast Cancer Undergoing Adjuvant or Neoadjuvant ChemotherapyClinical Breast Cancer, 2005
- Anemia in Stage II and III Breast Cancer Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide ChemotherapyThe Oncologist, 2004
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Epoetin Alfa Treatment Results in Clinically Significant Improvements in Quality of Life in Anemic Cancer Patients When Referenced to the General PopulationJournal of Clinical Oncology, 2003
- Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of HematologyJournal of Clinical Oncology, 2002
- Benefits of Epoetin Alfa in Anemic Breast Cancer Patients Receiving ChemotherapyClinical Breast Cancer, 2002
- Anemia as an independent prognostic factor for survival in patients with cancerCancer, 2001
- Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue CoalitionThe Oncologist, 2000
- Chemotherapy-Induced Anemia in Adults: Incidence and TreatmentJNCI Journal of the National Cancer Institute, 1999
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997